ATI Pathophysiology Exam 1 Related

Review ATI Pathophysiology Exam 1 related questions and content

What is the major effect of filgrastim (Neupogen) in a patient with chronic renal failure?

  • A. Decreases neutropenia related to chemotherapy
  • B. Decreases white blood cells related to infection
  • C. Decreases growth of blood vessels due to ischemia
  • D. Decreases platelet count related to bleeding
Correct Answer: A

Rationale: The major effect of filgrastim (Neupogen) is to stimulate the production of neutrophils, thereby decreasing neutropenia in patients undergoing chemotherapy. This medication helps the bone marrow produce more white blood cells, specifically neutrophils, to reduce the risk of infections associated with low neutrophil counts. Choices B, C, and D are incorrect because filgrastim does not decrease white blood cells related to infection, growth of blood vessels, or platelet count related to bleeding.